Plain-English translation of NCT05241236 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This clinical registry is collecting information from men with early-stage prostate cancer who undergo a targeted laser ablation procedure — a minimally invasive treatment that uses heat from a laser to destroy cancer cells in the prostate. Doctors use advanced imaging (MRI and ultrasound) to precisely guide the laser to the exact location of the cancer. The study will track how well this treatment controls the cancer and how it affects your quality of life over 1, 5, 10, and even 15 years.
Many men with early-stage prostate cancer want treatment options that are less invasive than surgery or radiation, with fewer side effects. This study exists to understand whether laser ablation is an effective and safe alternative for men with low- or intermediate-risk prostate cancer, and how it affects long-term cancer control and quality of life.
You likely qualify if…
You likely don't qualify if…
You will receive the laser ablation procedure in an office setting, where doctors use imaging to guide a laser to destroy your prostate cancer. After the procedure, you will have follow-up visits and imaging tests at 3 months, 6 months, 12 months, and then yearly for the duration of the study to check how well the treatment worked, look for any new tumors, and assess how the treatment has affected your urinary and sexual function. The study will continue to monitor your health and cancer status over 5–15 years.
AI-generated summary from trial data · Jul 12, 2026 · Not medical advice
United States
Sponsor
Urological Research Network, LLC
Enrollment target
~5,000 participants
Started
November 2020
Primary completion
November 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
50 Years and older
Sex
Male only
Last updated on clinicaltrials.gov in January 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
CIELO D GUERRA, BS
UROLOGICAL RESEARCH NETWORK
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.